| Subcutaneous low-molecular-weight heparin versus standard heparin and the prevention of thromboembolism in medical inpatients J Harenberg, P Roebruck, DL Heene Pathophysiology of Haemostasis and Thrombosis 26 (3), 127-139, 1996 | 190 | 1996 |
| Effect of dried garlic on blood coagulation, fibrinolysis, platelet aggregation and serum cholesterol levels in patients with hyperlipoproteinemia J Harenberg, C Giese, R Zimmermann Atherosclerosis 74 (3), 247-249, 1988 | 190 | 1988 |
| Risk stratification and heparin prophylaxis to prevent venous thromboembolism in pregnant women RM Bauersachs, J Dudenhausen, A Faridi, T Fischer, S Fung, U Geisen, ... Thrombosis and haemostasis 98 (12), 1237-1245, 2007 | 184 | 2007 |
| Effect of low molecular weight heparin (Certoparin) versus unfractionated heparin on cancer survival following breast and pelvic cancer surgery: A prospective randomized double … GF von Tempelhoff, J Harenberg, F Niemann, G Hommel, CJ Kirkpatrick, ... International journal of oncology 16 (4), 815-839, 2000 | 177 | 2000 |
| Reduction of platelet activity markers in type II hypercholesterolemic patients by a HMG-CoA-reductase inhibitor G Huhle, C Abletshauser, N Mayer, G Weidinger, J Harenberg, DL Heene Thrombosis research 95 (5), 229-234, 1999 | 175 | 1999 |
| Review of pharmacodynamics, pharmacokinetics, and therapeutic properites of sulodexide J Harenberg Medicinal research reviews 18 (1), 1-20, 1998 | 160 | 1998 |
| Inhibition of endothelial cell tube formation by the low molecular weight heparin, tinzaparin, is mediated by tissue factor pathway inhibitor SA Mousa, S Mohamed Thrombosis and haemostasis 92 (09), 627-633, 2004 | 152 | 2004 |
| Prophylaxis of thrombotic and embolic events in acute ischemic stroke with the low-molecular-weight heparin certoparin: results of the PROTECT Trial HC Diener, EB Ringelstein, R von Kummer, H Landgraf, K Koppenhagen, ... Stroke 37 (1), 139-144, 2006 | 141 | 2006 |
| Discovery of PG545: a highly potent and simultaneous inhibitor of angiogenesis, tumor growth, and metastasis V Ferro, L Liu, KD Johnstone, N Wimmer, T Karoli, P Handley, J Rowley, ... Journal of medicinal chemistry 55 (8), 3804-3813, 2012 | 138 | 2012 |
| Anti Xa monitoring during treatment with low molecular weight heparin or danaparoid: inter-assay variability S Kitchen, R Iampietro, AM Woolley, FE Preston Thrombosis and haemostasis 82 (10), 1289-1293, 1999 | 136 | 1999 |
| Randomized controlled study of heparin and low molecular weight heparin for prevention of deep-vein thrombosis in medical patients J Harenberg, B Kallenbach, U Martin, CE Dempfle, R Zimmermann, ... Thrombosis research 59 (3), 639-650, 1990 | 134 | 1990 |
| Pharmacology of low molecular weight heparins. J Harenberg Seminars in thrombosis and hemostasis 16, 12-18, 1990 | 128 | 1990 |
| Efficacy and safety of edoxaban in comparison with dabigatran, rivaroxaban and apixaban for stroke prevention in atrial fibrillation F Skjøth, TB Larsen, LH Rasmussen, GYH Lip Thrombosis and haemostasis 112 (05), 981-988, 2014 | 125 | 2014 |
| Is laboratory monitoring of low-molecular-weight heparin therapy necessary? Yes J Harenberg Journal of Thrombosis and Haemostasis 2 (4), 547-550, 2004 | 124 | 2004 |
| Therapeutic application of subcutaneous low-molecular-weight heparin in acute venous thrombosis J Harenberg, K Huck, H Bratsch, G Stehle, CE Dempfle, K Mall, M Blauth, ... Haemostasis 20 (Suppl 1), 205-219, 1990 | 112 | 1990 |
| Comparison of efficacy and safety of dabigatran, rivaroxaban and apixaban in patients with atrial fibrillation using network meta-analysis J Harenberg, S Marx, HC Diener, GY Lip, VJ Marder, M Wehling, C Weiss Database of Abstracts of Reviews of Effects (DARE): Quality-assessed Reviews …, 2012 | 111 | 2012 |
| Generation of anti-hirudin antibodies in heparin-induced thrombocytopenic patients treated with r-hirudin X Song, G Huhle, L Wang, U Hoffmann, J Harenberg Circulation 100 (14), 1528-1532, 1999 | 111 | 1999 |
| Characterization of heparins by high-performance size exclusion liquid chromatography J Harenberg, JX de Vries Journal of Chromatography A 261, 287-292, 1983 | 111 | 1983 |
| New developments in anticoagulants: past, present and future JI Weitz, J Harenberg Thrombosis and haemostasis 117 (07), 1283-1288, 2017 | 110 | 2017 |
| Bioavailability and antagonization of the low molecular weight heparin CY 216 in man J Harenberg, B Worzner, R Zimmermann, G Schettler Thrombosis research 44 (4), 549-554, 1986 | 108 | 1986 |
